NCT04211610Completed
Troponin Excretion in Urine in Patients With and Without Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 17 Jan 2024
Brief summary (registry, in English)
In this study, in order to better understand the mechanism of troponin clearance and the reason for elevated troponin levels in patients with CKD, we aim to evaluate quantitatively the excretion of troponin in the urine in patients with and without CKD, and with and without myocardial injury. We will compare urinary troponin levels with blood troponin levels in these patients. In addition, we will compare the levels of hs-cTnT and hs-cTnI in the patients' sera and urine.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 131 (actual)
- First submitted
- 23 Dec 2019
- Start date
- 1 Jan 2020
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Soroka University Medical Center
- Diseases
- Chronic kidney disease
- NCT number
- NCT04211610
What you commit to
- Study type: Observational
- Participants enrolled: 131
- From 1 Jan 2020 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients after kidney transplantation.
Other illness
- Patients after heart transplantation.
Other
- Pregnant women
- Anuric patients.
Who the study is looking for
- Patients who are able to give informed consent.
- Age ≥ 18
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Soroka Medical Center Coordinator of this site? Confirm its status | Beersheba | Israel | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.